EU multiple sclerosis Market Analysis

$3,500.00$7,500.00

  • Type: Common Disease Area
  • Published : January 2022
  • Region: Europe
  • Country: Other
  • Report ID : 5006

  • Format: PPT, PDF

EU multiple sclerosis Market Analysis: Segmented by Disease Type, Treatment, Drug Type, Route of Administration, End-User, Distribution Channel, Geography – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 5006 Categories: ,

Report Description of the EU Multiple Sclerosis Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for EU Multiple Sclerosis Market Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the EU Multiple Sclerosis Market Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

EU Multiple Sclerosis Market Analysis Executive Summary

Multiple sclerosis is a chronic, inflammatory, autoimmune disorder that affects the (CNS) central nervous system, especially the communication between the brain and other areas of the body. Multiple sclerosis (MS) in particular is a demyelinating disease that damages the insulating covers of nerve cells in the brain and spinal cord. There is usually no cure for MS, general care is based on speedy recovery from damage that delays disease progression and manages MS symptoms.

Market Size and Key Findings

The EU Multiple Sclerosis Market Analysis size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 6.3% during the forecast period.

The Multiple Sclerosis treatment market is expected to gain market growth in the forecast period of 2020 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.3% in the forecast period of 2020 to 2028 and is expected to reach USD 8,374.10 million by 2028. Rising awareness towards early disease diagnosis and technological advancement in multiple sclerosis treatment are the major drivers which propelled the demand of the multiple sclerosis treatment market in the forecast period.

Market Dynamics

Market Growth Drivers Analysis

The rising number of patients, increased screening and the need for better care options are thought to be the key factors for the multiple sclerosis treatment market growth during the forecast period. In ageing population, the disease is more prone, hence the surge in the geriatric population further escalates the multiple sclerosis treatment market growth.

Market Restraints

One of the major challenges in MS therapies market is the unknown etiology of the disease. Thus, it is difficult for medical researchers to develop drugs that target the key source of the disease. Despite increased government interventions and various treatment options for multiple sclerosis, the cost of drugs remains a major challenge for the growth of market. The high pricing of drugs makes it inefficient in addressing the unmet needs of affected populations. Moreover, it also adds to the economic burden globally due to increased out-of-pocket expenses. 3

COVID-19 impact on “EU Multiple Sclerosis Market Analysis” 

A notable disruption of rehabilitative therapy and home-based services as well as in DMT adherence was observed. Since the pandemic is still ongoing and interruption of healthcare services could have a major impact on MS patients, it is necessary to monitor access of MS patients to healthcare resources in order to ensure adequate treatments, including rehabilitative therapies.

Competitive Landscape

Key Players

The major players covered in the Europe multiple sclerosis treatment market report are Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceuticals Industries Ltd.), F. Hoffmann-La Roche Ltd, Merck KGaA, Mallinckrodt, Pfizer Inc., Hikma Pharmaceuticals PLC, Mylan N.V., Acorda Therapeutics, Inc., Novartis AG, Biogen, CELGENE CORPORATION (a subsidiary of Bristol-Myers Squibb Company), Lannett, Bayer AG, Amneal Pharmaceuticals LLC among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Products in Pipeline

In August 2020, Novartis AG received the U.S. FDA approval for its drug Kesimpta (ofatumumab) for the indication of treatment of relapsing multiple sclerosis. The new drug approval received by the company for its only self-administered targeted B-cell therapy for patients having relapsing MS has increased its demand in the market leading to increased revenue in future.

Notable Recent Deals

  • In 2020, Biogen launched a bold 20-year, $250 million initiative to address the deeply interrelated issues of climate, health, and equity. Healthy Climate, Healthy Lives™ aims to eliminate fossil fuels across the company’s operations, build collaborations with renowned institutions to advance the science to improve human health outcomes, and support underserved communities.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

The Multiple Sclerosis Foundation and affiliated groups have initiated National MS Education and Awareness Month, which is observed in March since 2003 to increase awareness about the disease. The goal of this program is to promote an understanding of multiple sclerosis disease and help the patients in making educated decisions regarding its treatment. Also, the National MS Society created and launched the “MS Kills Connection > < Connection Kills MS” campaign to connect people suffering from MS, people who treat MS patients, and people who run activities to create a world free of MS. Similarly, several players operating in the multiple sclerosis therapeutics market are developing and launching new products. The strategy of geographic and manufacturing capacity expansion, along with the product launches, helps companies cater to a broad customer base. Such developments and launches of new products are emerging as a key trend in the Europe multiple sclerosis therapeutics market.

1. Report Description of the EU multiple sclerosis Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. EU multiple sclerosis Market Analysis Executive Summary
2.1 EU multiple sclerosis Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of EU Multiple Sclerosis Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Increasing Prevalence of Multiple Sclerosis
3.1.2 Extensive research and development activity in multiple Sclerosis treatment
3.1.3 Rising government initiatives
3.1.4 Increasing need for better multiple Sclerosis treatment options
3.2 Market Restraints Analysis
3.2.1 Unspecified etiology of the disease
3.2.2 High cost of treatment
3.3 Covid-19 Market Impact Analysis
4. EU Multiple Sclerosis Market Segmentation
4.1 By Disease Type:
4.1.1 Relapsing–Remitting Multiple Sclerosis (RRMS)
4.1.2 Secondary Progressive Multiple Sclerosis (SPMS)
4.1.3 Primary Progressive Multiple Sclerosis (PPMS)
4.1.4 Severe Relapsing–Remitting Multiple Sclerosis (RES)
4.2 By Treatment:
4.2.1 Preventive Therapies
4.2.2 Abortive Therapies/Treatment of Acute Exacerbations
4.2.3 Symptomatic Therapies
4.3 By Drug Type:
4.3.1 Branded
4.3.2 Generic
4.4 By Route of Administration:
4.4.1 Oral
4.4.2 Parenteral
4.5 By End-User:
4.5.1 Hospitals
4.5.2 Home Care
4.5.3 Specialty Centers
4.5.4 Others
4.6 By Distribution Channel:
4.6.1 Retail Sales
4.6.2 Direct Tender
4.7 By Geography:
4.7.1 Germany
4.7.2 UK
4.7.3 France
4.7.4 Belgium
4.7.5 Rest of Europe
5. EU Multiple Sclerosis Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Sclerosis Market
6.4 Notable recent deals in Sclerosis Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Biogen Company overview
Product & Services, Strategies & Financials
7.2 Novartis AG Company overview
Product & Services, Strategies & Financials
7.3 Genzyme Corporation Company overview
Product & Services, Strategies & Financials
7.4 Merck KGAA Company overview
Product & Services, Strategies & Financials
7.5 Teva Pharmaceuticals USA, INC. Company overview
Product & Services, Strategies & Financials
7.6 F. Hoffmann-la ROCHE LTD Company overview
Product & Services, Strategies & Financials
7.7 Acorda Therapeutics, INC Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Sclerosis market
9.2 Future Opportunities
10. Strategic Recommendations

EU Multiple Sclerosis Market Analysis Segmentation

By Disease Type:

On the basis of disease type, the multiple sclerosis treatment market is segmented into relapsing–remitting multiple sclerosis (RRMS), secondary progressive multiple sclerosis (SPMS), primary progressive multiple sclerosis (PPMS) and severe relapsing–remitting multiple sclerosis (RES). In 2020, relapsing–remitting multiple sclerosis (RRMS) segment is dominating the multiple sclerosis treatment market because it is the most common form of multiple sclerosis at onset and accounts for about 85% of all cases.

By Treatment:

On the basis of treatment, the multiple sclerosis treatment market is segmented into symptomatic therapies, abortive therapies/treatment of acute exacerbations and preventive therapies. In 2020, preventive therapies segment is dominating the multiple sclerosis treatment market as the immune system eats away at the protective covering of nerves, and the prevention is highly sought after.

  • Preventive Therapies
  1. Oral Medication
    • Tecfidera
    • Gilenya
    • Aubagio
    • Mavenclad
    • Mayzent
    • Vumerity
    • Others
  2. Injectable Medication
    • Interferon Beta-1A
  • Avonex
  • Rebif
  • Others
    • Glatiramer Acetate
  • Copaxone
  • Glatopa
  • Others
    • Interferon BETA-1B
  • Betaseron
  • Extavia
    • Plegridy/Peginterferon BETA-1A
    • Chemotherapy Drug
    • Monoclonal Antibodies
  1. Infused Medication
    • Tysabri
    • Ocrevus
    • Lemtrada
    • Mitoxantrone
    • Novantrone
    • Others
  2. Haematopoietic Stem Cell Transplantation (HSCT)
  • Abortive Therapies/Treatment Of Acute Exacerbations
  1. Corticosteroids
    • Oral Prednisone
    • Methylprednisolone
    • Dexamethasone
    • Prednisolone
    • Betamethasone
    • Others
  2. Immunosuppressants
    • Azathioprine
    • Cyclophosphamide
    • Methotrexate
    • Mitoxantrone
    • Others
  3. Adrenocorticotropic Hormone
  4. Plasmapheresis
  5. Intravenous Immunoglobulin and
  6. Others
  • Symptomatic Therapies
  1. Muscle Relaxants
    • Lioresal
    • Zanaflex
    • Others
  2. Fatigue Medications
    • Gocovri
    • Osmolex
    • Provigil
    • Ritalin
    • Others
  3. Physiotherapy
  4. Laxatives

By Drug Type:

On the basis of drug type, the multiple sclerosis treatment market is segmented into branded and generic. In 2020, branded segment is dominating the multiple sclerosis treatment market because of large number of products which are being launched from time-to-time by several companies making it difficult for generics to take over the market.

By Route of Administration:

On the basis of route of administration, the multiple sclerosis treatment market is segmented into oral and parenteral. In 2020, oral segment is dominating the multiple sclerosis treatment market because of the increased bioavailability of the oral drug at the target site.

By End-User:

On the basis of end user, the multiple sclerosis treatment market is segmented into hospital, specialty centers, homecare and others. In 2020, hospital segment is dominating the multiple sclerosis treatment market because of the large number of patients visiting the hospitals due to the presence of skilled professionals and advanced technology for the diagnosis.

By Distribution Channel:

On the basis of distribution channel, the multiple sclerosis treatment market is segmented into direct tender and retail sales. In 2020, retail sales segment is dominating the multiple sclerosis treatment market because retail sales focus heavily on the costs associated with overhead and they provide instant gratification.

By Country:

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements